🇺🇸 FDA
Patent

US 10265410

Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects

granted A61KA61K31/37A61K31/42

Quick answer

US patent 10265410 (Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects) held by HALOZYME, INC. expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/37, A61K31/42, A61K31/573, A61K38/47